Radiotherapy for Bladder Cancer

Urology

Volumn 69, Issue 1 SUPPL., 2007, Pages 80-92

  Milosevic, Michael ^a   Gospodarowicz, Mary ^a   Zietman, Anthony ^b   Abbas, Farhat ^c   Haustermans, Karin ^d   Moonen, Luc ^e   Rödel, Claus ^f   Schoenberg, Mark ^g   Shipley, William ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^g DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; NICOTINAMIDE; VINBLASTINE;

ADJUVANT THERAPY; ARTICLE; BLADDER CANCER; BLADDER FUNCTION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CYSTECTOMY; DISEASE CONTROL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; INTERMETHOD COMPARISON; MULTIPLE CYCLE TREATMENT; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIOISOTOPE THERAPY; TRANSURETHRAL RESECTION; UNSPECIFIED SIDE EFFECT;

HUMANS; NEOPLASM INVASIVENESS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33846562138     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.05.060     Document Type: Article

References (102)

1. Milosevic M., Gospodarowicz M., Zietman A., et al. Radiotherapy for bladder cancer. In: Soloway M., Carmack A., and Khoury S. (Eds). Bladder Tumors (2006), Health Publications Ltd, Paris 359-382
2. Duncan W., and Quilty P.M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage x-ray therapy. Radiother Oncol 7 (1986) 299-310
3. Blandy J.P., Jenkins B.J., Fowler C.G., et al. Radical radiotherapy and salvage cystectomy for T2/3 cancer of the bladder. Prog Clin Biol Res 260 (1988) 447-451
4. Jenkins B.J., Caulfield M.J., Fowler B., et al. Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2/T3) bladder cancer. Br J Urol 62 (1988) 342-346
5. Borgaonkar S., Jain A., Bollina P., et al. Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder: results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) 14 (2002) 141-147
6. Greven K.M., Solin L.J., and Hanks G.E. Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer 65 (1990) 908-912
7. Smaaland R., Akslen L., Tonder B., et al. Radical radiation treatment of invasive and locally advanced bladder cancer in elderly patients. Br J Urol 67 (1991) 61-69
8. Vale J.A., A'Hern R.P., Liu K., et al. Predicting the outcome of radical radiotherapy for invasive bladder cancer. Eur Urol 24 (1993) 48-51
9. Gospodarowicz M.K., Rider W.D., Keen C.W., et al. Bladder cancer: long term follow-up results of patients treated with radical radiation. Clin Oncol 3 (1991) 155-161
10. Jahnson S., Pedersen J., and Westman G. Bladder carcinoma-a 20-year review of radical irradiation therapy. Radiother Oncol 22 (1991) 111-117
11. Fossa S.D., Waehre H., Aass N., et al. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer: a retrospective analysis of 317 patients. Cancer 72 (1993) 3036-3043
12. Pollack A., Zagars G.K., and Swanson D.A. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys 30 (1994) 267-277
13. Moonen L., Voet H., Nijs R., et al. Muscle-invasive bladder cancer treated with external beam radiotherapy: pretreatment prognostic factors and the predictive value of cystoscpic re-evaluation during treatment. Radiother Oncol 49 (1998) 149-155
14. Davidson S.E., Symonds R.P., Snee M.P., et al. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol 66 (1990) 288-293
15. Goffinet D.R., Schneider M.J., Glatstein E.J., et al. Bladder cancer: results of radiation therapy in 384 patients. Radiology 117 (1975) 149-153
16. Yu W.S., Sagerman R.H., Chung C.T., et al. Bladder carcinoma: experience with radical and preoperative radiotherapy in 421 patients. Cancer 56 (1985) 1293-1299
17. Goodman G.B., Hislop T.G., Elwood J.M., et al. Conservation of bladder function in patients with invasive bladder cancer treated by definitive irradiation and selective cystectomy. Int J Radiat Oncol Biol Phys 7 (1981) 569-573
18. Gospodarowicz M.K., Hawkins N.V., Rawlings G.A., et al. Radical radiotherapy for the muscle invasive transitional cell carcinoma of the bladder: failure analysis. J Urol 142 (1989) 1448-1454
19. Quilty P.M., Duncan W., Chisholm G.D., et al. Results of surgery following radical radiotherapy for invasive bladder cancer. Br J Urol 58 (1986) 396-405
20. Rodel C., Grabenbauer G., Kuhn R., et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20 (2002) 3061-3071
21. Werf-Messing B.H.P., and Hop W.C.L. Carcinoma of the urinary bladder (category T1NXM0) treated either by radium implant or by transurethral resection only. Int J Radiat Oncol Biol Phys 7 (1981) 299-303
22. Werf-Messing B., Menon R.S., and Hop W.C.J. Cancer of the urinary bladder category T2, T3, (NXM0) treated by interstitial radium implant: second report. Int J Radiat Oncol Biol Phys 9 (1983) 481-485
23. Wijnmaalen A., Helle P.A., Koper P.C.M., et al. Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192. Int J Radiat Oncol Biol Phys 39 (1997) 1043-1052
24. De Neve W., Lybeert M.L., Goor C., et al. T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative, or interstitial radiotherapy. Int J Radiat Oncol Biol Phys 23 (1992) 299-304
25. Rozan R., Albuisson E., Donnarieix D., et al. Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 24 (1992) 469-477
26. Moonen L.M., Horenblas S., van der Voet J.C., et al. Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation. Br J Urol 74 (1994) 322-327
27. Lerner S.P., Skinner D.G., Lieskovsky G., et al. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 149 (1993) 758-764
28. Frazier H.A., Robertson J.E., Dodge R.K., et al. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71 (1993) 3993-4001
29. Bassi P., Ferrante G.D., Piazza N., et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 161 (1999) 1494-1497
30. Skinner D.G., Tift J.P., and Kaufman J.J. High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer. J Urol 127 (1982) 671-674
31. Pollack A., Zagars G.K., Dinney C.P., et al. Preoperative radiotherapy for muscle-invasive bladder carcinoma: long term follow-up and prognostic factors for 338 patients. Cancer 74 (1994) 2819-2827
32. Cole C.J., Pollack A., Zagars G.K., et al. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone. Int J Radiat Oncol Biol Phys 32 (1995) 331-340
33. Anderstrom C., Johansson S., Nilsson S., et al. A prospective randomized study of preoperative irradiation with cystectomy or cystectomy alone for invasive bladder carcinoma. Eur Urol 9 (1983) 142-147
34. Smith J., Crawford E., Paradelo J., et al. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study. J Urol 157 (1997) 805-808
35. Ghoneim M.A., Ashamallah A.K., Awaad H.K., et al. Randomized trial of cystectomy with or without preoperative radiotherapy for carcinoma of the bilharzial bladder. J Urol 134 (1985) 266-268
36. Miller L.S. Bladder cancer: superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 39 (1977) 973-980
37. Sell A., Jakobsen A., Nerstrom B., et al. Treatment of advanced bladder cancer category T2, T3 and T4a. Scand J Urol Nephrol 138 (1991) 193-201
38. Bloom H.J., Hendry W.F., Wallace D.M., et al. Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy. Br J Urol 54 (1982) 136-151
39. Huncharek M., Muscat J., and Geschwind J.F. Planned preoperative radiation therapy in muscle invasive bladder cancer: results of a meta-analysis. Anticancer Res 18 (1998) 1931-1934
40. Shelley M., Wilt T., Barber J., et al. A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?. Clin Oncol 16 (2004) 166-171
41. Shipley W., Kaufman D., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-67
42. Zietman A., Sacco D., Skowronski U., et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J Urol 170 (2003) 1772-1776
43. Coppin C., Gospodarowicz M., James K., et al., National Cancer Institute of Canada Clinical Trials Group. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14 (1996) 2901-2907
44. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet 361 (2003) 1927-1934
45. Richards B., Bastable J.R.G., Freedman L., et al. Adjuvant chemotherapy with doxorubicin (Adriamycin) and 5-fluorouracil in T3, NX, MO bladder cancer treated with radiotherapy. Br J Urol 55 (1982) 386-391
46. Shearer R.J., Chilvers C.E.D., Bloom H.J.G., et al. Adjuvant chemotherapy in T3 carcinoma of the bladder: a prospective trial. Preliminary report. Br J Urol 62 (1988) 558-564
47. Wallace D.M.A., Raghavan D., Kelly K.A., et al. Neoadjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladder. Br J Urol 67 (1991) 608-615
48. Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16 (1998) 3576-3583
49. Sengelov L., von der Maase H., Lundbeck F., et al. Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours. Acta Oncol 41 (2002) 447-456
50. Ghersi D., Stewart L.A., Parmar M.K.B., et al. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet 354 (1999) 533-540
51. Farah R., Chodak G.W., Vogelzang N.J., et al. Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report). Int J Radiat Oncol Biol Phys 20 (1991) 413-417
52. Tester W., Caplan R., Heaney J., et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 14 (1996) 119-126
53. Wajsman Z., Marino R., Parsons J., et al. Bladder-sparing approach in the treatment of invasive bladder cancer. Semin Urol 8 (1990) 210-215
54. Hayter C.R.R., Paszat L.F., Groome P.A., et al. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 45 (1999) 1239-1245
55. Scrimger R., Murtha A., Parliament M., et al. Muscle-invasive transitional cell carcinoma of the urinary bladder: a population-based study of patterns of care and prognostic factors. Int J Radiat Oncol Biol Phys 51 (2001) 23-30
56. Abrams P, Grant A, and Khoury S. Evidence-based medicine: overview of the main steps for developing and grading guideline recommendations. In Abrams P, Cardozo L, Khoury S, et al (Eds), Incontinence, Volume 1. Plymouth, United Kingdom, Health Publications Ltd., pp 10-11.
57. Mameghan H., Fisher R., Mameghan J., et al. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 31 (1995) 247-254
58. Moonen L., Voet H., Nijs R., et al. Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys 42 (1998) 525-530
59. Quilty P.M., and Duncan W. Treatment of superficial (T1) tumours of the bladder by radical radiotherapy. Br J Urol 58 (1986) 147-152
60. Rodel C., Dunst J., Grabenbauer G., et al. Radiotherapy is an effective treatment for high-risk T1-bladder cancer. Strahlenther Onkol 177 (2001) 82-88
61. Shipley W.U., Rose M.A., Perrone T.L., et al. Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival. J Urol 134 (1985) 679-683
62. Shipley W.U., Prout G.R., Kaufman S.D., et al. Invasive bladder carcinoma: the importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation. Cancer 60 (1987) 514-520
63. Timmer P.R., Harlief H.A., and Hooijkaas J.A. Bladder cancer: pattern of recurrence in 142 patients. Int J Radiat Oncol Biol Phys 11 (1985) 899-905
64. Pollack A., Wu C.S., Czerniak B., et al. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res 3 (1997) 1823-1829
65. Pollack A., Czerniak B., Zagars G.K., et al. Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 39 (1997) 687-695
66. Moonen L., Ong F., Gallee M., et al. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys 49 (2001) 1305-1310
67. Chyle V., Pollack A., Czerniak B., et al. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 35 (1996) 281-287
68. Rodel C., Grabenbauer G.G., Rodel F., et al. Apoptosis, p53, bcl-2, and KI-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservation. Int J Radiat Oncol Biol Phys 46 (2000) 1213-1221
69. Fung C.Y., Shipley W.U., Young R.H., et al. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 9 (1991) 1533-1542
70. Wolf H., Olsen P.R., and Hojgaard K. Urothelial dysplasia concomitant with bladder tumours: a determinant for future new occurrences in patients treated by full-course radiotherapy. Lancet 1 (1985) 1005-1008
71. Zietman A., Grocela J., Zehr E., et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58 (2001) 380-385
72. Quilty P.M., and Duncan W. The influence of hemoglobin level on the regression and long term control of transitional cell carcinoma of the bladder following photon irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 1735-1742
73. Subarsky P., and Hill R. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 20 (2003) 237-250
74. Hoskin P., Sibtain A., Daley F., et al. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 89 (2003) 1290-1297
75. Fyles A., Milosevic M., Hedley D., et al. Tumor hypoxia is an independent predictor of outcome in patients with node negative cervix cancer. J Clin Oncol 20 (2002) 610-615
76. Brizel D.M., Scully S.P., Harrelson J.M., et al. Tumor oxygenation predicts for likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56 (1996) 941-943
77. Roy C., Bras Y.L., Mangold L., et al. Small pelvic lymph node metastases: evaluation with MR imaging. Clin Radiol 52 (1997) 437-440
78. Barentsz J.O., Witjes J.A., and Ruijs J.H. What is new in bladder cancer imaging. Urol Clin North Am 24 (1997) 583-602
79. 18F]-2-deoxy-D-glucose. Eur Urol 36 (1999) 582-587
80. Milosevic M., Gospodarowicz M., Jewett M., et al. Intensity-modulated radiation therapy (IMRT) for lymph node metastases in bladder cancer. In: Gregoire V., Scalliet P., and Ang K. (Eds). Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy (2003), Springer-Verlag, New York 157-169
81. Agranovich A., Czaykowski P., Hui D., et al. Radiotherapy for muscle-invasive urinary bladder cancer in elderly patients. Can J Urol 10 (2003) 2056-2061
82. Pisters L.L., Tykochinsky G., and Wajsman Z. Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. J Urol 146 (1991) 1514-1517
83. Palou J., Sanchez-Martin F.M., Rosales A., et al. Intravesical bacille Calmette-Guérin in the treatment of carcinoma in situ or high-grade superficial bladder carcinoma after radiotherapy for bladder carcinoma. BJU Int 83 (1999) 429-431
84. Thames H.D., and Hendry J.H. Fractionation in Radiotherapy (1987), Taylor and Francis Inc, London
85. Trott K.R., and Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation. Radiother Oncol 3 (1985) 1-9
86. Hainau B., and Dombernowsky P. Histology and cell proliferation in human bladder tumors. Cancer 33 (1974) 115-126
87. Rew D.A., Thomas D.J., Coptcoat M., et al. Measurement of in vivo urological tumour cell kinetics using multiplanar flow cytometry: preliminary study. Br J Urol 68 (1991) 44-48
88. Abratt R.P., Wilson J.A., Pontin A.R., et al. Salvage cystectomy after radical irradiation for bladder cancer-prognostic factors and complications. Br J Urol 72 (1993) 756-760
89. Blandy J.P., England H.R., Evans S.J., et al. T3 bladder cancer-the case for salvage cystectomy. Br J Urol 52 (1980) 506-510
90. Crawford E.D., and Skinner D.G. Salvage cystectomy after irradiation failure. J Urol 123 (1980) 32-34
91. Konnak J.W., and Grossman H.B. Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of bladder. Urology 26 (1985) 550-553
92. Nurmi M., Valavaara R., Puntala P., et al. Single-stage salvage cystectomy: results and complications in 20 patients. Eur Urol 16 (1989) 89-91
93. Smith J.A., and Whitmore W.F. Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol 125 (1981) 643-645
94. Swanson D.A., Eschenbach A.C., Bracken R.B., et al. Salvage cystectomy for bladder carcinoma. Cancer 47 (1981) 2275-2279
95. Osborn D.E., Honan R.P., Palmer M.K., et al. Factors influencing salvage cystectomy results. Br J Urol 54 (1982) 122-125
96. Bochner B.H., Figueroa A.J., Skinner E.C., et al. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol 160 (1998) 29-33
97. Mannel R.S., Manetta A., Buller R.E., et al. Use of ileocecal continent urinary reservoir in patients with previous pelvic irradiation. Gynecol Oncol 59 (1995) 376-378
98. Skinner D.G., Daniels J.R., Russell C.A., et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 145 (1991) 459-464
99. Freiha F., Reese J., and Torti F.M. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155 (1996) 495-499
100. Stockle M., Meyenburg W., Wellek S., et al. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 153 (1995) 47-52
101. Studer U.E., Bacchi M., Biedermann C., et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 152 (1994) 81-84
102. Maase H., Hansen S.W., Roberts J.T., et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18 (2000) 3068-3077